急性心肌梗死静脉溶栓治疗１６０例临床分析作者：潘永丽 吴宗劲来源：《中国医药导报》2009年第23期
[摘要] 目的:探讨静脉溶栓治疗急性心肌梗死(AMI)的临床效果。方法:应用尿激酶进行静脉溶栓治疗早期AMI患者160例。结果:本组108例再通,再通率为67.5%。其中6 h内AMI患者再通94例,再通率为87.0%(94/108)。本组死亡4例,死亡率为2.5%。结论:对于AMI患者,只要具有溶栓指征而无禁忌证,应尽可能早地应用尿激酶进行静脉溶栓,再通率高,副作用小,值得推广应用。
[关键词] 急性心肌梗死;静脉溶栓;尿激酶;再通;并发症
[中图分类号] R542.2+2[文献标识码]A [文章编号]1673-7210(2009)08(b)-021-02
Clinical analysis of 160 cases of acute myocardial infarction treated with intravenous thrombolytic therapy
PAN Yongli, WU Zongjin
(1.Department of Internal Medicine, the Hospital in the East Coast of Gaozhou City, Guangdong Province, Gaozhou 525232, China; 2.Chinese Medicine Hospital of Gaozhou City, Guangdong Province, Gaozhou 525200, China)
[Abstract] Objective: To explore the clinical effect of intravenous thrombolytic therapy on acute myocardial infarction (ACI). Methods: Intravenous urokinase thrombolysis was applied to treat 160 cases of patients with early AMI. Results: There were 108 cases of recanalization in this group, the recanalization rate was 67.5%. Among these cases, 94 cases of patients with AMI developed recanalization within 6 h, the recanalization rate was 87.0% (94/108). 4 cases died in this group, the mortality rate was 2.5%. Conclusion: For patients with AMI as long as with thrombolytic therapy and without contraindications indications, the application of intravenous urokinase thrombolysis should be developed as soon as possible, the recanalization rate is high, the side effects is tiny, and it is worth popularizing.
本文来源：https://www.2haoxitong.net/k/doc/fcb99333f605cc1755270722192e453611665b65.html
文档为doc格式